Cargando…

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis

We report a 14-year-old girl with juvenile dermatomyositis (JDM) complicated by severe inflammatory calcinosis successfully treated with thalidomide. She was diagnosed as JDM when she was 4 years old after a few months of increasing lethargy, muscle pain, muscle weakness, and rash. During three mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamae, Takako, Sano, Fumie, Ozawa, Remi, Imagawa, Tomoyuki, Inayama, Yoshiaki, Yokota, Shumpei
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831027/ https://www.ncbi.nlm.nih.gov/pubmed/20181085 http://dx.doi.org/10.1186/1546-0096-8-6

Ejemplares similares

Efficacy of thalidomide for a girl with inflammatory calicinosis, a severe complication of juvenile dermatomyosistis
por: Miyamae, T, et al.
Publicado: (2008)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
por: Miyamae, Takako, et al.
Publicado: (2011)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2016)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

46 Universal calcinosis in juvenile dermatomyositis: a case report
por: Bahaz, N, et al.
Publicado: (2022)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
por: Hisa, Kaori, et al.
Publicado: (2017)

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis
por: Gunawardena, H, et al.
Publicado: (2009)

Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
por: Orandi, Amir B., et al.
Publicado: (2018)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Initial manifestations and risk factors for calcinosis in juvenile dermatomyositis: A retrospective multicenter study
por: Cakan, Mustafa, et al.
Publicado: (2023)

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
por: Kishi, Takayuki, et al.
Publicado: (2021)

Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report
por: Velma, Selmanovic-Mulaosmanovic, et al.
Publicado: (2011)

Muscular Weakness with Calcinosis Cutis_A Case of Juvenile Dermatomyositis in a South Asian Male
por: Khan, Qaisar Ali, et al.
Publicado: (2023)

Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy
por: Miyamae, Takako, et al.
Publicado: (2005)

A case of adult dermatomyositis with calcinosis universalis
por: Jayanthi, Mohan Roop, et al.
Publicado: (2014)

PW02-024 - A case of candle syndrome treated with thalidomide
por: Yamazaki, K, et al.
Publicado: (2013)

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
por: Tansley, Sarah L., et al.
Publicado: (2014)

Juvenile dermatomyositis‐associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy
por: Agud‐Dios, Manuel, et al.
Publicado: (2022)

Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
por: Orandi, A. B., et al.
Publicado: (2017)

Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis
por: Wakabayashi, Takayuki, et al.
Publicado: (2015)

Juvenile dermatomyositis in a 4‐year‐old Kenyan girl
por: Grijsen, Marlous L., et al.
Publicado: (2017)

Juvenile dermatomyositis in a 14-year old Nigerian girl
por: Aliu, Rasaki, et al.
Publicado: (2021)

Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
por: Yokota, Shumpei, et al.
Publicado: (2021)

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
por: Nikishina, IP, et al.
Publicado: (2013)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
por: Toplak, Natasa, et al.
Publicado: (2022)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

Subcutaneous Calcinosis in a Patient with Anti-MDA5 Positive Dermatomyositis
por: Hou, Ruihong, et al.
Publicado: (2021)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population
por: Kadota, Keisuke, et al.
Publicado: (2013)

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
por: Mori, Masaaki, et al.
Publicado: (2008)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
por: Gunawardena, H, et al.
Publicado: (2008)

Abatacept in the Treatment of Juvenile Dermatomyositis-Associated Calcifications in a 16-Year-Old Girl
por: Sukumaran, Sukesh, et al.
Publicado: (2020)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bk5etn3cmcearou940i6q5kecc